Tuesday, January 13, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Insider Trading

Semiconductor Espionage Scandal Rocks Industry as TSMC Investigates Former Executive

Robert Sasse by Robert Sasse
November 28, 2025
in Insider Trading, Mergers & Acquisitions, Semiconductors, Tech & Software
0
TSMC Stock
0
SHARES
14
VIEWS
Share on FacebookShare on Twitter

The global semiconductor sector faces a dramatic corporate espionage case following raids conducted by Taiwanese investigators at the home of a former TSMC senior executive. Authorities are investigating allegations that Lo Wei-jen, who recently joined Intel after 21 years with TSMC, stole highly sensitive technical secrets regarding advanced 2nm, 3nm, and 5nm chip fabrication processes to accelerate Intel’s foundry ambitions.

Legal Battle Intensifies Between Chip Giants

TSMC has responded aggressively to the suspected intellectual property theft, filing lawsuits accusing its former senior vice president of violating non-compete agreements. The legal action demonstrates the company’s determination to protect its technological advantages—often described as its competitive “moat.” Intel has categorically denied the allegations, stating it finds no merit in the claims against its newly hired executive.

The investigation reached its peak on Wednesday and Thursday when Taiwan’s Intellectual Property Court authorized searches of Lo’s residence. The case highlights the intense competition within the semiconductor industry as companies race to develop next-generation manufacturing capabilities.

Massive Expansion Amidst Legal Challenges

While legal proceedings advance, TSMC continues to reinforce its market leadership through substantial capital investment. Industry reports indicate the chipmaker plans to construct three additional 2nm fabrication plants in Taiwan, representing an estimated $28 billion investment in advanced manufacturing capacity.

This expansion strategy underscores TSMC’s confidence in sustained demand for artificial intelligence and high-performance computing chips. Despite competitive pressure from Intel’s upcoming “18A” technology node, TSMC’s aggressive capacity buildup signals its commitment to maintaining manufacturing supremacy regardless of legal disputes or competitive threats.

Should investors sell immediately? Or is it worth buying TSMC?

Market Confidence Remains Strong

Financial analysts maintain positive assessments of TSMC’s fundamental position, viewing the legal controversy as having limited impact on the company’s long-term prospects. The stock retains its “Strong Buy” rating among most Wall Street experts, with consensus price targets exceeding $348 per share—indicating significant potential upside from current levels.

TSMC shares continue trading near yearly highs, currently valued at €250.50 and approaching the 52-week peak of €265.00. Market experts consider this valuation justified given TSMC’s dominant position in high-end chip manufacturing for industry leaders including Nvidia and Apple.

Trading Session and Technical Outlook

As U.S. markets reopen following the holiday, attention turns to how investors will respond to the espionage allegations. Technical analysis identifies the $275-$280 range as crucial support, with the psychological $300 barrier representing the next significant resistance level.

For shareholders, the critical question remains whether this legal confrontation will substantially delay Intel’s efforts to close the technological gap with TSMC. For now, the semiconductor leader appears firmly in control, combining legal action with massive capacity expansion to secure its industry position.

Ad

TSMC Stock: Buy or Sell?! New TSMC Analysis from January 13 delivers the answer:

The latest TSMC figures speak for themselves: Urgent action needed for TSMC investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 13.

TSMC: Buy or sell? Read more here...

Tags: TSMC
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

CureVac Stock
Mergers & Acquisitions

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
PayPal Stock
Analysis

Analyst Downgrade Overshadows PayPal’s Strategic Moves

January 13, 2026
Fiserv Stock
AI & Quantum Computing

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

January 13, 2026
Next Post
Texas Instruments Stock

Insider Selling Spree Raises Red Flags for Texas Instruments

Nuscale Power Stock

NuScale Power Shares Plunge Following Analyst Downgrade

Boeing Stock

Boeing Stock Surges on $15 Billion Order Windfall

Recommended

Tesla Stock

Tesla’s Strategic Pivot: A Three-Pronged Transformation

2 months ago
Nio Stock

Nio’s Billion-Dollar Equity Raise Sends Shares Tumbling

4 months ago
Weyerhaeuser Stock

Weyerhaeuser Stock: A Study in Contradictory Market Signals

5 months ago
Assembly Biosciences Stock

Assembly Biosciences Shares Maintain Strong Upward Momentum

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Pfizer’s Strategic Shift Weighs on Investor Sentiment

Analyst Downgrade Overshadows PayPal’s Strategic Moves

Ethereum’s Quiet Consolidation Masks a Strengthening Foundation

Fiserv Embarks on Strategic AI Push Amid Leadership Reshuffle

Alphabet Reaches Historic Valuation Milestone on Dual Strategic Wins

A Regulatory Milestone Sparks Renewed Interest in Sangamo Therapeutics

Trending

Novo Nordisk Stock
Earnings

Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach

by Dieter Jaworski
January 13, 2026
0

In a strategic pivot aimed at capturing a broader patient base, Novo Nordisk is aggressively promoting a...

CureVac Stock

CureVac’s Stock Journey Concludes Following BioNTech Acquisition

January 13, 2026
MSCI World ETF Stock

A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

January 13, 2026
Pfizer Stock

Pfizer’s Strategic Shift Weighs on Investor Sentiment

January 13, 2026
PayPal Stock

Analyst Downgrade Overshadows PayPal’s Strategic Moves

January 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Novo Nordisk Bets on Oral Wegovy to Expand Weight-Loss Market Reach
  • CureVac’s Stock Journey Concludes Following BioNTech Acquisition
  • A Deep Dive into the iShares MSCI World ETF’s Performance and Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com